A detailed history of Gts Securities LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Gts Securities LLC holds 4,448 shares of CTLT stock, worth $262,876. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,448
Previous 15,000 70.35%
Holding current value
$262,876
Previous $843,000 68.09%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$56.16 - $60.96 $38,750 - $42,062
690 Added 18.36%
4,448 $269,000
Q2 2024

Aug 14, 2024

BUY
$53.58 - $57.02 $201,353 - $214,281
3,758 New
3,758 $211,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.6B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.